Kenya Pharmaceutical Import Regulations: PPB Guide

The Pharmacy and Poisons Board (PPB): Who They Are

The Pharmacy and Poisons Board (PPB) is Kenya's national medicines regulatory authority, established under the Pharmacy and Poisons Act (Cap 244). Unlike some African regulators that handle everything from food to cosmetics, PPB focuses exclusively on human and veterinary medicines, medical devices, and pharmaceutical raw materials.

PPB's core functions:

• Product registration and licensing
• Inspecting manufacturing facilities (GMP audits)
• Issuing import and export permits
• Pharmacovigilance and post-market surveillance
• Inspecting wholesale and retail pharmacies
• Controlling controlled substances (narcotics, psychotropics)

PPB has a reputation for being pragmatic and efficient by African standards. Their online portal (known as the Integrated Management System or IMS) actually works. Response times to queries are measured in weeks, not months. And they've embraced the EAC harmonization agenda wholeheartedly.

Registration Categories & Pathways

PPB offers multiple registration pathways depending on your product type and approval status elsewhere.

Category 1: New Chemical Entities (NCEs)

Full clinical trial data required. Timeline: 12-18 months. This pathway is rare for most generic exporters.

Category 2: Generic Products (EAC CTD Format)

This is the pathway for 90% of pharmaceutical imports into Kenya. Requires bioequivalence data or a BCS-based biowaiver. Timeline: 6-12 months.

Category 3: EAC Joint Assessment Procedure

The gold standard for East Africa. One dossier reviewed by a team of experts from multiple EAC countries leads to simultaneous approvals in Kenya, Uganda, Tanzania, Rwanda, Burundi, and South Sudan. Timeline: 4-8 months for assessment, plus national administrative steps.

Category 4: SRA/WHO PQ Fast-Track

Products with WHO Prequalification or approval by a Stringent Regulatory Authority (US FDA, EMA, Health Canada, TGA, PMDA) qualify for accelerated review. Reduced dossier requirements. Timeline: 3-5 months.

Category 5: Locally Manufactured Products

Kenya has strong local manufacturing incentives. Products made within the EAC region receive priority processing and reduced fees.

Category 6: Over-the-Counter (OTC) & Herbal Products

Simplified documentation. No bioequivalence studies required. Timeline: 4-8 months.

Step-by-Step Registration Process

Here's the actual process for registering a pharmaceutical product with PPB. Follow these steps precisely.

Step 1: Appoint a Local Agent (Kenyan Importer/Distributor)

Foreign manufacturers cannot hold a PPB registration. You need a Kenyan company with a valid PPB wholesale license to be your local agent. This company will be the registered importer of record. Choose carefully—you're legally married to them for the registration's duration.

Step 2: Execute a Power of Attorney (PoA)

A notarized document authorizing your Kenyan agent to act on your behalf. Must be apostilled or legalized at the Kenyan embassy in your country.

Step 3: Obtain a Certificate of Pharmaceutical Product (CPP)

Issued by the regulatory authority in your manufacturing country. Must be in WHO format, less than 2 years old, and properly legalized. PPB is strict about this.

Step 4: Prepare Your Dossier in EAC CTD Format

PPB follows the EAC Common Technical Document (CTD) format, which is aligned with the ICH CTD. See the detailed dossier section below.

Step 5: Submit via PPB's IMS Portal

Your Kenyan agent logs into the PPB Integrated Management System (IMS), uploads the dossier (PDFs), and pays the application fee online. You'll receive an acknowledgement receipt with a reference number.

Step 6: Administrative Screening (2-4 weeks)

PPB checks for completeness. Missing documents, improper legalization, or invalid CPP results in a deficiency letter. Each correction cycle adds 2-4 weeks.

Step 7: Scientific Evaluation (3-8 months)

PPB evaluators review your dossier for quality, safety, and efficacy. They issue queries (requests for additional information) via the IMS portal. You typically have 60-90 days to respond. Well-prepared dossiers might have 1-2 query cycles.

Step 8: GMP Inspection (If Required)

If your facility hasn't been inspected by PPB before (or within the last 3 years), they will schedule an inspection. PPB accepts WHO PQ and SRA inspections as evidence, potentially waiving physical inspection. See inspection section below.

Step 9: Registration Committee Approval (2-4 weeks)

The PPB Product Evaluation Committee meets monthly. They issue final approval or rejection. Approved products receive a Certificate of Registration with a unique PPB registration number (e.g., "CT 12345").

Step 10: Publication in PPB Gazette (2-4 weeks)

Approved products are published in the official PPB Gazette. Your registration is legally effective from the publication date.

Dossier Requirements: The Kenyan CTD

PPB follows the EAC CTD format, which mirrors the ICH CTD structure. Here's exactly what goes into each module.

Module 1: Administrative Information (Country-Specific)

• Application letter on manufacturer letterhead
• Cover letter from Kenyan agent
• Power of Attorney (notarized, apostilled)
• Certificate of Pharmaceutical Product (WHO format, notarized, legalized)
• GMP Certificate from manufacturing country (notarized, legalized)
• Free Sale Certificate or Certificate of Export
• Manufacturing license from country of origin
• Product samples information (batch numbers, quantities)
• Labeling and package insert (mock-ups)
• Patent declaration (product doesn't infringe Kenyan patents)

Module 2: Summaries

• Quality Overall Summary (QOS)
• Nonclinical Overview & Summary (for NCEs)
• Clinical Overview & Summary (or Bioequivalence summary)

Module 3: Quality (Pharmaceutical Documentation)

• Drug substance (API): Manufacturing process, characterization, impurity profile, specifications
• Drug product: Formulation, manufacturing process, specifications, excipients
• Stability data: Zone IV (hot & humid) conditions. Minimum 6 months accelerated, 12 months long-term at submission.
• Container closure system: Packaging specifications

Module 4: Nonclinical Reports (NCEs Only)

• Pharmacology, pharmacokinetics, toxicology studies

Module 5: Clinical Reports

• For generics: Bioequivalence study report comparing your product to the reference product (must be the innovator product registered in Kenya)
• For NCEs: Full clinical trial reports
• For OTC: Literature review and safety references

The EAC Advantage: One Dossier, Six Markets

This is the most important section in this guide. Kenya is part of the East African Community (EAC) Medicines Regulatory Harmonization program, which is the most advanced pharmaceutical harmonization initiative in Africa.

How the EAC Joint Assessment Procedure (JAP) works:

1. You submit one dossier to the EAC Secretariat in Arusha, Tanzania (or through your chosen reference national regulator).
2. The dossier is evaluated by a joint team of experts from all participating EAC countries (Kenya, Uganda, Tanzania, Rwanda, Burundi, South Sudan).
3. Once approved at the regional level, you obtain individual national registrations from each country—but the scientific assessment is done once.
4. Timeline for regional assessment: 4-8 months. Then 1-3 months for each national administrative step.

The massive advantage: Instead of submitting six separate dossiers to six different regulators (each with different requirements and timelines), you submit one dossier once. This saves you 12-24 months and $20,000-$50,000 in duplication costs.

The catch: Not all products are eligible. The EAC JAP currently focuses on essential medicines, generics, and products with WHO PQ. Novel therapies and complex biologics may need to go through individual national pathways. Check with the EAC Secretariat for current eligibility.

Import Permits & Pre-Shipment Requirements

Registration is just the beginning. For each commercial shipment, you need a specific import permit from PPB. Here's how it works.

Import Permit Process:

1. Your Kenyan agent logs into the PPB IMS portal.
2. They submit an import permit application, specifying:
   • Product name and PPB registration number
   • Quantity (number of packs/units)
   • Batch numbers
   • Manufacturing date and expiry date
   • Port of entry (Mombasa, JKIA, or other)
   • Expected arrival date
3. PPB reviews and issues the import permit (typically 3-7 days).
4. The permit is valid for a specific shipment and timeframe (usually 3-6 months).

What You Need Before Shipping:

• Valid PPB import permit
• Commercial invoice and packing list
• Bill of lading or airway bill
• Certificate of Analysis for the specific batch
• GMP certificate (copy)
• Product registration certificate (copy)
• Temperature monitoring data (for cold chain products)

Mombasa Port Clearance: What to Expect

Mombasa is East Africa's busiest port, handling over 90% of Kenya's international trade. Clearing pharmaceutical products here requires coordination between multiple agencies.

The Agencies Involved:

• PPB Port Office: Verifies import permit, takes samples for testing, issues release order
• Kenya Revenue Authority (KRA) Customs: Assesses and collects import duties and taxes
• Kenya Bureau of Standards (KEBS): Verifies product standards (some products)
• Kenya Ports Authority (KPA): Manages port operations and container storage

The Clearance Process:

1. Arrival Notification: Shipping line notifies your clearing agent of arrival.
2. Entry Filing: Your customs clearing agent files an entry with KRA via the Simba system.
3. PPB Inspection: PPB port officers inspect the shipment, verify documents, and may take samples for laboratory testing.
4. Customs Assessment: KRA assesses duties (import duty: 0-25% depending on product, VAT: 16%).
5. Payment: Your agent pays duties and taxes online.
6. Release Order: PPB issues a release order once satisfied.
7. Physical Delivery: Container is released for pickup.

Typical Timelines:

• Straightforward shipment (established importer, good compliance record): 3-7 days
• First-time importer or random sample required: 7-14 days
• Shipment with issues (missing documents, suspicious product): 14-30+ days

Hidden Costs to Budget For:

• Demurrage: KES 5,000-10,000 ($35-70) per day after free storage period (typically 4-7 days)
• Port storage fees: KES 2,000-5,000 ($14-35) per day
• Clearing agent fees: KES 30,000-100,000 ($200-700) per container
• PPB sample testing fees: KES 20,000-50,000 ($140-350) if random testing is required

Costs, Timelines & Hidden Expenses

Let's get real about what you'll spend and how long it'll take.

Official PPB Fees (Approximate, subject to change)

• Application fee: KES 10,000-25,000 ($70-175)
• Evaluation fee: KES 50,000-150,000 ($350-1,050) depending on product category
• Registration certificate fee: KES 20,000-50,000 ($140-350)
• Annual retention fee: KES 10,000-30,000 ($70-210) per product per year
• Import permit fee: KES 2,000-5,000 ($14-35) per shipment

Third-Party Costs (Your Real Expenses)

• Regulatory consultant fees: $3,000-$10,000 per product
• Document legalization/apostille: $500-$2,000
• GMP inspection (if required): $8,000-$15,000 plus inspector travel
• Bioequivalence study: $50,000-$150,000 if new study needed
• Stability studies (Zone IV): $10,000-$30,000
• Clearing agent fees per shipment: $200-$700

Total Estimated Cost Per Product:

• Generic (EAC CTD, no inspection, existing BE data): $6,000-$12,000
• Generic (with GMP inspection): $15,000-$25,000
• EAC Joint Assessment Procedure: $10,000-$20,000 (but covers multiple countries)
• SRA/WHO PQ Fast-Track: $4,000-$8,000

Timelines:

• Fast-Track (SRA/WHO PQ): 3-5 months
• Standard generic (well-prepared dossier): 6-9 months
• Standard generic (poor dossier, multiple queries): 9-15 months
• EAC JAP (regional assessment): 4-8 months plus national steps

Common Pitfalls & Rejection Reasons

After analyzing PPB rejection data, here are the most common reasons applications fail.

• Invalid or Expired CPP: CPP more than 2 years old or not in WHO format. Automatic rejection.
• Missing Notarization/Apostille: All foreign documents must be notarized and apostilled. PPB will not accept plain copies.
• Incorrect Reference Product for Bioequivalence: Your BE study must compare against the innovator product registered in Kenya, not a different market. Many Indian manufacturers use the wrong reference product.
• Inadequate Stability Data: Zone II stability data (Mediterranean climate) is rejected. Zone IV (tropical) is required.
• GMP Certificate Issues: Certificate must be current (usually within 3 years) and cover your specific dosage form.
• Product Sample Fails Testing: PPB will take samples for testing. If your product fails quality tests, registration is rejected.
• Labeling Errors: Your proposed labeling must include the PPB registration number (once assigned), batch number, manufacturing date, expiry date, and storage conditions.

Post-Registration Obligations

Registration is not a one-time event. PPB has ongoing requirements.

• Annual Retention Fees: Payable each year. Late payment incurs penalties. Non-payment for 2+ years leads to deregistration.
• Variations: Any change to manufacturing site, formulation, or specifications requires PPB notification. Major changes require a variation application with fees.
• Renewal: Initial registration is valid for 5 years (for most products). Renewal requires updated dossiers, current GMP, and evidence of continued compliance. Start renewal 6 months before expiry.
• Pharmacovigilance: You must have a PV system to report adverse events to PPB. Periodic Safety Update Reports (PSURs) are required every 2 years.
• Batch Testing (for some products): Vaccines, biologics, and certain high-risk products require lot release testing by PPB before distribution.

Kenya vs. Other East African Markets

The winning strategy: Register first in Kenya (or Rwanda for speed), then use the EAC Joint Assessment Procedure to expand to other EAC countries. This gives you access to 300+ million people with minimal duplication of effort.

Conclusion: Your Kenya Entry Strategy

Kenya offers one of the most accessible and rewarding pharmaceutical markets in Africa—but only if you respect the system. The PPB is efficient but strict. They've invested in digital infrastructure, embraced regional harmonization, and created clear pathways for compliant exporters.

Your Kenya entry checklist:

• ✓ Find a reputable Kenyan importer/distributor with a clean compliance record
• ✓ Execute a proper Power of Attorney (notarized, apostilled)
• ✓ Obtain a valid CPP (WHO format, less than 2 years old)
• ✓ Prepare your dossier in EAC CTD format with Zone IV stability data
• ✓ Consider the EAC Joint Assessment Procedure if targeting multiple markets
• ✓ Budget $10,000-$20,000 per product for registration (all-in)
• ✓ Plan for 6-9 months from submission to approval (standard pathway)
• ✓ Hire a specialized clearing agent for Mombasa port clearance
• ✓ Build a relationship with your local agent—they're your legal face in Kenya
• ✓ Stay current on annual fees and pharmacovigilance reporting

The companies that succeed in Kenya are the ones who treat it as a strategic market, not a side project. They invest in local relationships, maintain regulatory excellence, and use Kenya as a springboard to the entire East African region. Do it right, and Kenya will reward you with consistent, growing demand for years to come.

And here's the best part: once you're registered in Kenya through the EAC JAP, you're 80% of the way to Uganda, Tanzania, Rwanda, and Burundi. That's the power of regulatory harmonization—and it's why Kenya should be your first stop in East Africa.